ANTIEMETIC ACTIVITIES OF INDONESIAN STINGLESS BEE PROPOLIS ON EMETIC INDUCED BY ANTI-TUBERCULOSIS DRUGS
Objective: This study aims to determine the antiemetic potential of stingless bee propolis in reducing the prevalence of nausea due to consumption of Anti-Tuberculosis Drugs (ATD) in Tuberculosis patients and to identify phytochemical compounds that act as an antiemetic in propolis.
Methods: The stingless bee propolis used was Wallacetrigona incisa from South Sulawesi. The clinical testing used the randomized controlled trial, randomization using permuted block randomization consisting of one positive control group and two treatment groups. The active components analyzed using Gas Chromatography-Mass Spectrometer (GC-MS) pyrolyzer.
Results: This study found that the measurement at week 0 obtained the mean value of nausea per week for each group P0 (Placebo), P1 (Propolis 6%), and P2 (Propolis 30%) were respectively 2.14; 1.5 and 5.2 events/week, at week 8 the prevalence of nausea by 2.0; 1.0; and 1.6 events/week, and week 24 the prevalence of nausea by 3.0; 0; and 0 events/week. There are 11 compounds with concentrations above 1% that act as antiemetic compounds either through direct and indirect mechanism with a total concentration reaches 75,47%.
Conclusion: Based on all determinant parameters, propolis of Wallacetrigona incisa species from South Sulawesi has antiemetic activity and can reduce the prevalence of emetic induced by ATD consumption in pulmonary TB patients.
2. S Raghavan, P Manzanillo, K Chan, C Dovey, JS Cox. Secreted transcription factor controls mycobacterium tuberculosis virulence. Nature 2008;454:717-21.
3. Kementerian Kesehatan Republik Indonesia. Buku Pedoman Nasional Pengendalian Tuberkuolsis; 2014.
4. A Abbas. Monitoring efek samping obat anti-tuberkulosis (OAT) pada pengobatan tahap intensif penderita TB paru di kota makassar. J Agromed Med Sci 2017;1:19.
5. M Mahani, A Sulaeman, F Anwar, MRM Damanik, H Hardinsyah, A Ploeger. Efficacy of propolis supplementation to accelerate healing process and body weight recovery of pulmonary tuberculosis patients. J Gizi Dan Pangan 2018;1:1-10.
6. AM Fikri, A Sulaeman, SA Marliyati, M Fahrudin. Antiemetic activity of trigona spp. propolis from three provinces of Indonesia with two methods of extraction. Pharmacogn J 2018;10:120-2.
7. M Eda, Y Hayashi, K Kinoshita, K Koyama, K Takahashi, K Akutu. Anti-emetic principles of water extract of Brazilian propolis. Pharm Biol 2005;2:184-8.
8. VS Bankova, SL De Castro, MC Marcucci. Propolis: recent advances in chemistry and plant origin. Apidologie 2000;1:3-15.
9. N Kalsum, A Sulaeman, B Setiawan, IWT Wibawan. Phytochemical profiles of propolis trigona spp. from three regions in Indonesia using GC-MS. J Biol Agric Health 2016;14:31-7.
10. B Nurhadi, E Subroto, M Herudiyanto. Bee propolis trigona spp potential and uniqueness in Indonesia. Proceeding Univ Malaysia Teren Annu Sci; 2011.
11. A Sulaeman, AM Fikri, N Kalsum, M Mahani. Trigona propolis and its potency for health and healing process. Elsevier Inc; 2019.
12. M Mahani, A Sulaeman, F Anwar, MRM Damanik H, A Ploeger. Determination of Indonesian native stingless bee propolis as complementary nutraceutical candidate of an anti-tuberculosis drug. Int J Pharm 2018;4:15.
13. S Ahmed, MM Hasan, SW Ahmed, Z Alam Mahmood, I Azhar, S Habtemariam. Anti-emetic effects of bioactive natural products. Phytopharmacology 2013;2:390-433.
14. L Zheng, LK Shi, C Zhao, QZ Jin, XG Wang. Fatty acid, phytochemical, oxidative stability and in vitro antioxidant property of sea buckthorn (Hippophaë rhamnoides L.) oils extracted by supercritical and subcritical technologies. Food Sci Tech 2017;86:507-13.
15. SC Chow, JP Liu. Sample size calculations in clinical research. 2nd ed. Chapman and Hall/CRC biostatistics series; 2008.
16. JC Herlambang Pranandaru, Adi Sembodo. Propolis sebagai suplemen bagi pasien tuberkulosis dewasa. PKM Penelitian. Dikti Kemendikbud; 2014.
17. CC Liu, JM Hsu, LK Kuo, CP Chuu. Caffeic acid phenethyl ester as an adjuvant therapy for advanced prostate cancer. Med Hypotheses 2013;5:617-9.
18. L Denholm, G Gallagher. Physiology and pharmacology of nausea and vomiting. Anaesth Intensive Care Med 2018;9:513-6.
19. CD Balaban, BJ Yates. What is nausea? A historical analysis of changing views. Auton Neurosci Basic Clin 2017;202:5-17.
20. W Zhao, Y Weng. A simplified formula for quantification of the probability of deterministic assignments in permuted block randomization. J Stat Plan Inference 2011;1:474-8.
21. ST Omaye. Food and Nutritional Toxicology; 2004.
22. MA Arbex, M de CL Varella, HR de Siqueira, FAF de Mello. Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 2: second-line drugs. J Bras Pneumol 2010;5:641-56.
23. A Zumla, P Nahid, ST Cole. Advances in the development of new tuberculosis drugs and treatment regimens. Nat Rev Drug Discovery 2013;5:388-404.
24. A Singh, R Prasad, V Balasubramanian, N Gupta, P Gupta. Prevalence of adverse drug reaction with first-line drugs among patients treated for pulmonary tuberculosis. Clin Epidemiol Glob Heal 2015;3:S88-90.
25. TE Chang, YS Huang, CH Chang, CL Perng, YH Huang, MC Hou. The susceptibility of anti-tuberculosis drug-induced liver injury and chronic hepatitis C infection: a systematic review and meta-analysis. J Chinese Med Assoc 2018;2:111-8.
26. ZH Zhang, JH Tang, ZL Zhan, XL Zhang, HH Wu, YN Hou. Cellular toxicity of isoniazid together with rifampicin and the metabolites of isoniazid on QSG-7701 hepatocytes. Asian Pac J Trop Med 2012;4:306-9.
27. P Shang. Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug-induced liver injury (ATLI) in China. PLoS One 2011;7:1-7.
28. KC Chang, CC Leung, WW Yew, TY Lau, CM Tam. Hepatotoxicity of pyrazinamide: cohort and case-control analyses. Am J Respir Crit Care Med 2008;12:1391-6.
29. U Bharti, NR Kumar, J Kaur. Protective effect of bee propolis against anti-tuberculosis drugs (Rifampicin and isoniazid)-induced hematological toxicity in sprague dawley rats. Asian J Pharm Clin Res 2017;3:188-90.
30. EI Ginns. A juvenile form of glycerol kinase deficiency with episodic vomiting, acidemia, and stupor. J Pediatr 1984;5:736-9.
31. DR Sjarif, JK Ploos Van Amstel, M Duran, FA Beemer, BT Poll. The isolated and contiguous glycerol kinase gene disorders: a review. J Inherit Metab Dis 2000;6:529-47.
32. OE Adelakun, T Kudanga, IR Green, M Le Roes Hill, SG Burton. Enzymatic modification of 2,6-dimethoxyphenol for the synthesis of dimers with high antioxidant capacity. Process Biochem 2012;12:1926-32.
33. QUA Shaikh. 1,2,3,4,6-Pentakis[-O-(3,4,5-trihydroxybenzoyl)]-?,?-D-glucopyranose (PGG) analogs: design, synthesis, anti-tumor and anti-oxidant activities. Carbohydr Res 2016;430:72-81.
34. BM Escribano. Dose-dependent S-allyl cysteine ameliorates multiple sclerosis disease-related pathology by reducing oxidative stress and biomarkers of dysbiosis in experimental autoimmune encephalomyelitis. Eur J Pharmacol 2017;815:266-73.
35. H Becerril Chavez. Protective effects of S-allyl cysteine on behavioral, morphological and biochemical alterations in rats subjected to chronic restraint stress: antioxidant and anxiolytic effects. J Funct Foods 2017;35:105-14.
36. LQ Lien. New naphthalene derivatives and isoquinoline alkaloids from ancistrocladus cochinchinensis with their anti-proliferative activity on human cancer cells. Bioorganic Med Chem Lett 2016;16:3913-7.
37. AY Tijani, SE Okhale, FE Oga, SZ Tags, OA Salawu, BA Chindo. Anti-emetic activity of grewia lasiodiscus root extract and fractions. Afr J Biotechnol 2008;17:3011-6.
38. NT Giang An. Mosquito larvicidal activity, antimicrobial activity, and chemical compositions of essential oils from four species of myrtaceae from central Vietnam. Plants 2020;9:554.
39. J Waikedre. Antifungal activity of the essential oils of callitris neocaledonica and c. sulcata heartwood (Cupressaceae). Chem Biodivers 2012;9:644-53.
40. H Noureddine. Chemical characterization and cytotoxic activity evaluation of lebanese propolis. Biomed Pharmacother 2017;95:298-307.
41. H Yang, Z Huang, Y Huang, W Dong, Z Pan, L Wang. Characterization of Chinese crude propolis by pyrolysis-gas chromatography/mass spectrometry. J Anal Appl Pyrolysis 2015;113:158-64.
42. YQ Hu. Isoniazid derivatives and their anti-tubercular activity. Eur J Med Chem 2017;133:255-67.
43. D Erlianda, MF Rizal, and S. B. Budiardjo. Antibacterial effect of flavonoids from propolis produced by trigona on atpase activity of streptococcus mutans. Int J Appl Pharm 2017;2:6-9.
44. WP Melinda, N Soedarsono, R Farida. Effects of propolis extract and propolis candies against candida albicans ATCC 10231 growth. Asian J Pharm Clin Res 2017;10:20-2.
45. Q Wang. Physcion 8-O-?-glucopyranoside suppresses tumor growth of hepatocellular carcinoma by downregulating PIM1. Biomed Pharmacother 2017;92:451-8.
46. AC Nascimento. Antiviral activity of faramea bahiensis leaves on dengue virus type-2 and characterization of a new antiviral flavanone glycoside. Phytochem Lett 2017;19:220-5.
47. DR Sjarif. Clinical heterogeneity and novel mutations in the glycerol kinase gene in three families with isolated glycerol kinase deficiency. J Med Genet 1998;8:650-6.
48. MS Baliga. Phytochemicals in the prevention of ethanol-induced hepatotoxicity: A revisit. Elsevier Inc; 2019.
49. E Ramos Tovar, P Muriel. Phytotherapy for the liver. no. 253037. Elsevier Inc; 2019.
50. J Robinson, EA Newsholme. Some properties of hepatic glycerol kinase and their relation to the control of glycerol utilization. Biochem J 1969;4:455-64.
51. DG Johnston, KGMM Alberti, R Wright, PG Blain. Glycerol clearance in alcoholic liver disease. Gut 1982;4:257-64.
52. A Sulaeman, M Mahani, H Hardinsyah, E Darma, SR Mubarokah, N Nurjanah. Hepatoprotective activity of Indonesian stingless bee propolis against toxicity of anti-tuberculosis drug on pulmonary tb patients. Apiterapi ve Doga Derg. J Apitherapy Nat 2018;3:10.
53. Z Kokanova Nedialkova, P Nedialkov, M Kondeva Burdina, R Simeonova, V Tzankova, D Aluani. Chenopodium bonus henricus L.–A source of hepatoprotective flavonoids. Fitoterapia 2017;118:13-20.
54. J Vinholes, A Rudnitskaya, P Gonçalves, F Martel, MA Coimbra, SM Rocha. Hepatoprotection of sesquiterpenoids: a quantitative structure-activity relationship (QSAR) approach. Food Chem 2014;146:78-84.
This work is licensed under a Creative Commons Attribution 4.0 International License.